Circumstantial considerations that support a link between the metabolic syndrome and LPS signaling include the increased cardiovascular risk in patients with the metabolic syndrome and the positive association of TLR4 activity with atherosclerosis progression in mice and human beings (24–28). Here, TLR4 is linked to metabolic syndrome.